Literature DB >> 26202338

Long-term phosphodiesterase 5 inhibitor administration reduces inflammatory markers and heat-shock proteins in cavernous tissue of Zucker diabetic fatty rat (ZDF/fa/fa).

J E Toblli1, G Cao1, M Angerosa1, M Rivero1.   

Abstract

Oxidative stress and nitrosative stress present in type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS) induce inflammatory response in diverse tissues including cavernous tissue (CT). Heat-shock proteins (HSPs) have an important role in modulating and repairing tissue injury, although their participation in CT in T2DM is unclear. Beyond the specific action of phosphodiesterase type 5 inhibitors (PDE5i) on erectile function, it has been proposed that chronic administration of these agents improves endothelial function and ameliorates fibrotic changes. The aim of this study was to determine in CT of Zucker Diabetic Fatty (ZDF) rat, an experimental model of T2DM and MS: (1) the degree of oxidative stress and nitrosative stress; (2) the magnitude of inflammatory markers such as tumor necrosis factor-α (TNFα) and interleukin 6 (IL6); (3) immunoexpression of HSP70 and HSP27; (4) how a long-term PDE5i administration may modify these variables. For 6 months, (1) untreated ZDF; (2) ZDF+Sildenafil (Sil) and (3) control Lean Zucker Rat (LZR) received no treatment, were studied. Penises were processed for functional 'in vitro' studies, oxidative and nitrosative stress evaluation and immunohistochemistry in CT using TNFα; IL6; nitrotyrosine, HSP70 and HSP27 antibodies. ZDF+Sil presented better relaxation in corporal strips versus untreated ZDF. Furthermore, ZDF+Sil presented less lipoperoxidation in CT versus untreated ZDF. The activity of antioxidant enzymes CuZn superoxide dismutase (CuZnSOD) and glutathione peroxidase (GPx) was also reduced in untreated ZDF in CT along with a decrease in glutathione versus untreated ZDF. Nitrotyrosine expression was increased in untreated-ZDF rats versus ZDF+Sil and LZR. TNFα and IL6 were decreased in CT in ZDF+Sil versus untreated ZDF. Additionally, the expression of HSP70 and HSP27 was reduced in CT in ZDF+Sil versus untreated ZDF. In conclusion, this study provides substantial evidence supporting a protective role of a long-term therapy with Sil on CT in a recognized animal model of T2DM and MS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202338     DOI: 10.1038/ijir.2015.13

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  57 in total

1.  A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts.

Authors:  F Paoletti; D Aldinucci; A Mocali; A Caparrini
Journal:  Anal Biochem       Date:  1986-05-01       Impact factor: 3.365

Review 2.  Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction.

Authors:  Antonio Aversa; Roberto Bruzziches; Marcello Pili; Giovanni Spera
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

3.  Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.

Authors:  S A Ballard; C J Gingell; K Tang; L A Turner; M E Price; A M Naylor
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

Review 4.  Small artery structure and hypertension: adaptive changes and target organ damage.

Authors:  Ashley S Izzard; Damiano Rizzoni; Enrico Agabiti-Rosei; Anthony M Heagerty
Journal:  J Hypertens       Date:  2005-02       Impact factor: 4.844

5.  Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit.

Authors:  Annamaria Morelli; Paolo Comeglio; Sandra Filippi; Erica Sarchielli; Linda Vignozzi; Elena Maneschi; Ilaria Cellai; Mauro Gacci; Andrea Lenzi; Gabriella B Vannelli; Mario Maggi
Journal:  Prostate       Date:  2012-09-19       Impact factor: 4.104

6.  Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.

Authors:  Linda Vignozzi; Sandra Filippi; Paolo Comeglio; Ilaria Cellai; Erica Sarchielli; Annamaria Morelli; Giulia Rastrelli; Elena Maneschi; Andrea Galli; Gabriella Barbara Vannelli; Farid Saad; Edoardo Mannucci; Luciano Adorini; Mario Maggi
Journal:  Mol Cell Endocrinol       Date:  2014-01-31       Impact factor: 4.102

7.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  Functional and morphological improvement in erectile tissue of hypertensive rats by long-term combined therapy with phosphodiesterase type 5 inhibitor and losartan.

Authors:  Jorge Eduardo Toblli; Gabriel Cao; Alejandra Lombraña; Miguel Rivero
Journal:  J Sex Med       Date:  2007-09       Impact factor: 3.802

9.  Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.

Authors:  Arthur L Burnett; Travis D Strong; Bruce J Trock; Liming Jin; Trinity J Bivalacqua; Biljana Musicki
Journal:  J Urol       Date:  2008-11-14       Impact factor: 7.450

10.  Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction.

Authors:  Istvan Kovanecz; Gaby Nolazco; Monica G Ferrini; Jorge E Toblli; Sanaz Heydarkhan; Dolores Vernet; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  BJU Int       Date:  2009-01-19       Impact factor: 5.588

View more
  1 in total

1.  Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.

Authors:  Mona Mohamed El-Naa; Mohamed Othman; Sheren Younes
Journal:  Drug Des Devel Ther       Date:  2016-11-16       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.